If you only tracked American insurance technology companies that went public recently, you might think insurtech is in its flop era.
Thankfully, that isn’t true.
The Exchange explores startups, markets and money.
Read it every morning on TechCrunch+ or get The Exchange newsletter every Saturday.
We saw earlier this week how the falling valuations of public insurtech companies have coincided with a decline in VC interest in the category.
The funding climate for late-stage startups in the sector has consequently been tough, but there’s plenty of optimism around the newest generation of
コメント